222 related articles for article (PubMed ID: 10791469)
21. Immunohistochemistry with keratin, vimentin, desmin, and alpha-smooth muscle actin monoclonal antibodies in canine mammary gland: benign mammary tumours and duct ectasias.
Vos JH; van den Ingh TS; Misdorp W; Molenbeek RF; van Mil FN; Rutteman GR; Ivanyi D; Ramaekers FC
Vet Q; 1993 Sep; 15(3):89-95. PubMed ID: 7505510
[TBL] [Abstract][Full Text] [Related]
22. Myoepithelial cells in canine mammary tumours.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; Reymundo C; Espinosa de Los Monteros A; Martín de Las Mulas J
Vet J; 2016 Jan; 207():45-52. PubMed ID: 26639832
[TBL] [Abstract][Full Text] [Related]
23. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
24. Expression of beta 1 integrin in normal, dysplastic and neoplastic canine mammary gland.
Restucci B; De Vico G; Maiolino P
J Comp Pathol; 1995 Aug; 113(2):165-73. PubMed ID: 8543673
[TBL] [Abstract][Full Text] [Related]
25. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localisation of cytokeratin and vimentin intermediate filament proteins in canine mammary tumours.
Rabanal RM; Else RW
Res Vet Sci; 1994 Mar; 56(2):225-33. PubMed ID: 7514803
[TBL] [Abstract][Full Text] [Related]
27. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
28. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
29. Preliminary report on the expression of leptin and leptin receptor (ObR) in normal, hyperplastic and neoplastic canine mammary tissues.
Ressel L; Finotello R; Innocenti VM; Vannozzi I; Poli A
Res Vet Sci; 2012 Aug; 93(1):343-9. PubMed ID: 21875727
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
31. Cellular proliferative and telomerase activity in canine mammary gland tumors.
Funakoshi Y; Nakayama H; Uetsuka K; Nishimura R; Sasaki N; Doi K
Vet Pathol; 2000 Mar; 37(2):177-83. PubMed ID: 10714647
[TBL] [Abstract][Full Text] [Related]
32. Glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase activities in normal canine mammary gland and in mammary tumours and their correlation with oestrogen receptors.
Nerurkar VR; Ishwad CS; Seshadri R; Naik SN; Lalitha VS
J Comp Pathol; 1990 Feb; 102(2):191-5. PubMed ID: 2324341
[TBL] [Abstract][Full Text] [Related]
33. Studies on histogenesis of mixed tumours of the mammary gland in bitches.
Smiech A; Lopuszyński W; Nozdryn-Płotnicki Z
Pol J Vet Sci; 2002; 5(4):217-22. PubMed ID: 12512553
[TBL] [Abstract][Full Text] [Related]
34. Expression of Arginine Vasopressin Type 2 Receptor in Canine Mammary Tumours: Preliminary Results.
Benavente MA; Bianchi CP; Aba MA
J Comp Pathol; 2020 Aug; 179():36-40. PubMed ID: 32958145
[TBL] [Abstract][Full Text] [Related]
35. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
Ressel L; Millanta F; Poli A
J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
[TBL] [Abstract][Full Text] [Related]
36. Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance.
Millanta F; Calandrella M; Vannozzi I; Poli A
Vet Rec; 2006 Jun; 158(24):821-4. PubMed ID: 16782855
[TBL] [Abstract][Full Text] [Related]
37. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
[TBL] [Abstract][Full Text] [Related]
39. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
40. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]